Status:
UNKNOWN
Impact of Endometrial Compaction in Euploid Frozen Embryo Transfers
Lead Sponsor:
Boston IVF
Conditions:
Infertility, Female
Eligibility:
FEMALE
18-44 years
Brief Summary
The purpose of this pilot study is to evaluate whether a decrease in endometrial thickness (compaction) prior to progesterone exposure (endogenous or exogenous) to the day before a single frozen embry...
Detailed Description
Methods: Study participation will not influence any element of IVF treatment and all participants will be receiving the standard of care at Boston IVF. Potential participants will be identified by a m...
Eligibility Criteria
Inclusion
- Single euploid frozen embryo transfer
- ≥ 7 mm endometrial lining on transvaginal ultrasound
- 1st or 2nd frozen embryo transfer
Exclusion
- Obesity with body mass index \> 40
- Underweight with body mass index \< 18.5
- Utilization of a gestational carrier
- History of recurrent pregnancy loss (≥ 2 spontaneous abortions)
- Uterine factors (history of uterine adhesions, uterine surgery, fibroids, polyps)
- History of an endometrial receptivity assay (ERA) biopsy
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
187 Patients enrolled
Trial Details
Trial ID
NCT04330066
Start Date
September 1 2020
End Date
June 30 2022
Last Update
March 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston IVF
Boston, Massachusetts, United States, 02109